Liver fibrosis evaluation in lean steatotic liver disease patients

被引：0
|
作者：
Testino, Gianni [1 ,2 ,3 ]
机构：
[1] ASL3 Liguria, IRCCS San Martino Univ Hosp, Alcohol Reg Ctr, Unit Addict & Hepatol, Piazzale R Benzi 10, I-16132 Genoa, Italy
[2] ASL3 Liguria, Ctr Studi Mutual Self Help, Genoa, Italy
[3] ASL3, Dept Hlth Lifestyles, Genoa, Italy
来源：
MINERVA GASTROENTEROLOGY | 2024年
关键词：
D O I：
10.23736/S2724-5985.24.03686-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Non-invasive biomarkers of liver fibrosis may be used for diagnosing fibrosis and prognostication in patients with metabolic dysfunction-associated steatotic liver disease
    Hetland, Liv Eline
    Werge, Mikkel
    Thing, Mira
    Rashu, Elias
    Nabilou, Puria
    Kimer, Nina
    Junker, Anders
    Leeming, Diana
    Karsdal, Morten
    Guiliani, Alejandro Mayorca
    Gluud, Lise Lotte
    JOURNAL OF HEPATOLOGY, 2024, 80 : S513 - S513
  • [42] Visceral Fat and Diabetes: Associations With Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kumar, Ashish
    Arora, Anil
    Sharma, Praveen
    Jan, Shayesta
    Ara, Ishrat
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
  • [43] The Impact of Japanese Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
    Sasada, Takafumi
    Iino, Chikara
    Sato, Satoshi
    Tateda, Tetsuyuki
    Igarashi, Go
    Yoshida, Kenta
    Sawada, Kaori
    Mikami, Tatsuya
    Nakaji, Shigeyuki
    Sakuraba, Hirotake
    Fukuda, Shinsaku
    NUTRIENTS, 2024, 16 (17)
  • [44] Real world evaluation of a primary care pathway for the assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)
    Ahmad, Basil
    Mitchell, Oliver
    Pannifex, Sally
    Singanayagam, Arjuna
    Hughes, Sarah
    Clark, Sarah
    Yalcin, Metin
    Williams, Nicola
    Davie, Sarah
    Forton, Daniel
    JOURNAL OF HEPATOLOGY, 2024, 80 : S523 - S523
  • [45] Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
    Ballestri, Stefano
    Mantovani, Alessandro
    Di Girolamo, Maria
    Baldelli, Enrica
    Capitelli, Mariano
    Lonardo, Amedeo
    METABOLISM AND TARGET ORGAN DAMAGE, 2023, 3 (01):
  • [46] Treatment of liver cirrhosis in the era of steatotic liver disease
    Shimizu, Masahito
    HEPATOLOGY RESEARCH, 2024, 54 (08) : 727 - 728
  • [47] Metabolic dysfunction-associated steatotic liver disease, liver fibrosis and risk of cardiovascular disease: A prospective cohort study
    Baek, Ji Woo
    Yang, Yeun Soo
    Jung, Keum Ji
    Kimm, Heejin
    Kim, So Young
    Lee, Sunmi
    Jee, Sun Ha
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (12) : 2623 - 2629
  • [48] HIGH PREVALENCE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN LEAN AND NON-LEAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
    Mohamed, Mouhand F.
    Beran, Azizullah
    Chu, Jacqueline J.
    Yang, Wen T.
    Rajadurai, Suvithan
    Ghabril, Marwan S.
    Shah, Samir A.
    Njei, Basile
    GASTROENTEROLOGY, 2024, 166 (05) : S1643 - S1643
  • [49] Association of liver fibrosis progression with non-liver-related mortality in metabolic dysfunction-associated steatotic liver disease
    Tada, Toshifumi
    Kumada, Takashi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Koshiyama, Yuichi
    Akita, Tomoyuki
    Kodama, Yuzo
    Tanaka, Junko
    HEPATOLOGY RESEARCH, 2025,
  • [50] Fatty liver in lean patients: is it a different disease?
    Machado, Mariana Verdelho
    Cortez-Pinto, Helena
    ANNALS OF GASTROENTEROLOGY, 2012, 25 (01): : 1 - 2
12345